These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. Fahrenkrug J; Schaffalitzky de Muckadell OV J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156 [TBL] [Abstract][Full Text] [Related]
4. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)]. Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378 [TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment. Bloom SR Am J Dig Dis; 1978 Apr; 23(4):373-6. PubMed ID: 208414 [No Abstract] [Full Text] [Related]
6. Radioimmunoassay of gastrointestinal hormones. Straus E Gastroenterology; 1978 Jan; 74(1):141-52. PubMed ID: 336449 [No Abstract] [Full Text] [Related]
7. Vasoative intestinal peptide and the watery diarrhea syndrome. Ebeid AM; Murray PD; Fischer JE Ann Surg; 1978 Apr; 187(4):411-6. PubMed ID: 148246 [TBL] [Abstract][Full Text] [Related]
8. Watery diarrhea syndrome with elevated levels of vasoactive intestinal polypeptide associated with pancreatitis and pancreatic pseudocyst. Burbige EJ; Manning RJ; Belber JP Am J Gastroenterol; 1978 Aug; 70(2):136-40. PubMed ID: 717364 [TBL] [Abstract][Full Text] [Related]
9. [Study on the release of vasoactive intestinal polypeptide during hemorrhagic shock]. Sakio H Masui; 1983 Jan; 32(1):67-73. PubMed ID: 6842817 [No Abstract] [Full Text] [Related]
10. Plasma VIP in patients with watery diarrhea syndrome. Gardner JD Am J Dig Dis; 1978 Apr; 23(4):370-3. PubMed ID: 665633 [No Abstract] [Full Text] [Related]
11. Vasoactive intestinal peptide inhibition of stimulated gastric secretion. I. Inhibition of meat-stimulated gastric secretion. Ebeid AM; Escourrou J; Fischer JE Am J Surg; 1980 Jun; 139(6):817-23. PubMed ID: 7386736 [TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide-associated inhibition of stimulated gastric secretion. II. Inhibition of pentagastrin-stimulated gastric secretion. Escourrou J; Ebeid AM; Fischer JE Am J Surg; 1980 Jun; 139(6):824-8. PubMed ID: 7386737 [TBL] [Abstract][Full Text] [Related]
13. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man. Burhol PG; Waldum HL; Jorde R; Lygren I Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513 [TBL] [Abstract][Full Text] [Related]
14. Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs. Chayvialle JA; Miyata M; Rayford PL; Thompson JC Gastroenterology; 1980 Nov; 79(5 Pt 1):844-52. PubMed ID: 6106620 [TBL] [Abstract][Full Text] [Related]
15. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP). Fahrenkrug J; Schaffalitzky de Muckadell OB Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790 [TBL] [Abstract][Full Text] [Related]
16. [Sympathoma and diarrhea caused by hypersecretion of vasoactive intestinal peptide (VIP). Apropos of a further case]. Fontaine JL; Girardet JP; Bataille D; Lagardère B; Lemerle J Arch Fr Pediatr; 1977; 34(6):577-8. PubMed ID: 907439 [No Abstract] [Full Text] [Related]
17. An increase in vasoactive intestinal peptide levels in canine endotoxin shock. Freund H; Ebeid AM; Fischer JE Surg Gynecol Obstet; 1981 May; 152(5):604-6. PubMed ID: 7221842 [TBL] [Abstract][Full Text] [Related]
18. [Gastrin, VIP and other gastrointestinal hormones]. Yamaguchi K; Abe K Rinsho Byori; 1985 May; 33(5):534-8. PubMed ID: 4057638 [No Abstract] [Full Text] [Related]